Upexi (GRVI) Stock Analysis

What Upexi does

Upexi, Inc., through its various divisions, specializes in the development, production, promotion, and sale of items containing cannabidiol (CBD) derived from industrial hemp. These offerings span from foundational raw materials to private-label products and direct-to-consumer goods. The company's reach extends across multiple consumer markets, including botanicals, personal grooming, animal wellness, and health-oriented foods. Furthermore, it organizes a yearly trade exposition focused on the CBD industry within the United States. Established in 2018, Upexi's corporate headquarters are situated in Henderson, Nevada.

Key metrics

ETFs linked to GRVI

Broad-market and Healthcare sector ETFs an investor holding Upexi is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GRVI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Upexi?

Upexi trades under the ticker GRVI on NASDAQ.

Which exchange is GRVI listed on?

GRVI is listed on NASDAQ.

What sector does Upexi operate in?

Upexi is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze GRVI in a portfolio?

PortView shows GRVI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.